ADLM 2026: Machine Learning Tumor Test Accuracy - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

ADLM 2026: Machine Learning Tumor Test Accuracy

Study shows why laboratories must validate artificial intelligence models beyond performance alone

  • August 4, 2026

  • 3 min

Share

  • 1

    Machine learning improved diagnostic accuracy of plasma metanephrine testing for adrenal tumors in a large study.

  • 2

    The study evaluated over 20,500 adults who underwent plasma-free metanephrine testing at Samsung Medical Center.

  • 3

    Combining laboratory results with structured clinical information enhanced diagnostic interpretation significantly.

  • 4

    The best-performing model increased the area under the curve from 0.81 to 0.91 with added clinical data.

  • 5

    Robust validation and transparency are essential for effective machine learning implementation in laboratory diagnostics.

Original Source(s)

ADLM 2026: Machine Learning Tumor Test Accuracy

  • August 4, 2026

Related Content

Inflammatory myofibroblastic tumour: unravelling the interplay of inflammation, kinase signalling, and therapeutic resistance

Herbal targeting of mitochondrial dynamic proteins in low-density lipoprotein driven atherosclerosis in vitro

Narrow DCIS Margins May Not Always Warrant Reexcision

An ancillary analysis found less than 2-percentage-point differences in 10-year recurrence across margin thresholds, with no statistically significant adjusted association.